Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2/3 1

Status

Suspended 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 11Breast 9Head & Neck 7Lymphoid 6Other hematologic neoplasm 4Other 3Genitourinary 2Tumor-Agnostic 1Thoracic 1Plasma cell 1Myeloid 1Gynecologic 1Dermatologic 1CNS 1

Conditions

Prostatic Neoplasms 2Pain 1Agnosia 1

Interventions

Docetaxel 390pembrolizumab 325Prednisone 284Gemcitabine 273enzalutamide 254Radiotherapy 251Nivolumab 247Magnetic Resonance Spectroscopy 247Cisplatin 209Abiraterone Acetate 197Radiosurgery 184Leuprolide 182Sunitinib 169Carboplatin 161bicalutamide 148Goserelin 145Androgen Antagonists 142Specimen Handling 138Ipilimumab 128Paclitaxel 125Cyclophosphamide 116acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 110Bevacizumab 109Everolimus 107apalutamide 98cabozantinib 97abiraterone 97Sorafenib 97atezolizumab 96Radiation 89

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Ketamine × Genitourinary × Clear all
NCT05597878 2026-05-26

Opioid-Free Pain Control Regimen Following Robotic Radical Prostatectomy

Wake Forest University Health Sciences

Phase 2/3 Suspended
100 enrolled
Genitourinary

Agnosia, Prostatic Neoplasms

NCT02909049 2018-01-26

Clinical Trial to Examine Individual Pain Tolerance in the Use of Two Anesthetic Techniques to Perform Saturation Prostate Biopsy

Complexo Hospitalario Universitario de A Coruña

Phase 4 Completed
100 enrolled
Genitourinary

Pain, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡